Subscribe to Newsletter

Clinical Trials

Business & Regulation COVID-19

Cutting Through the Noise

| Stephanie Vine

We curate the COVID-19 news and breakthroughs of 2020 to bring you a helicopter view of the global fight against COVID-19.

Discovery & Development Clinical Trials

Green Trials

| Stephanie Vine

Implementing green practices in clinical trials.

Discovery & Development Vaccines

The Pfizer COVID-19 Vaccine

| Stephanie Vine

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

Discovery & Development Clinical Trials

Pandemic Protection

| Stephanie Vine

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Vine

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

Manufacture Bioprocessing - Single Use Systems

The Power List 2021: Nominate Now

| Stephanie Vine

Nominations are now open for The Medicine Maker 2021 Power List.

Discovery & Development Clinical Trials

A Matter of Trust

| Maryam Mahdi

Can we trust the integrity of clinical trials?

Discovery & Development Clinical Trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Business & Regulation Supply Chain

Airplane Blues

| James Strachan

From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.

Business & Regulation Business Practice

Access Not Denied

| Stephanie Vine

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine